Top Back to top

Meet the Expert Sessions

Meet the Expert sessions are an opportunity for delegates to sit down and converse on a more one-to-one level with the experts in their field. The schedule for the Meet the Expert Sessions will be released soon.

Please note that the virtual Meet the Expert sessions will be conducted on a first-come, first-served basis, and anyone registered to the general Annual Meeting will be eligible to attend through the virtual Meet the Expert video rooms in the virtual event platform. The Quality Management MTE sessions work differently and need pre-registration through the general form.

Supporting companies provide additional Meet the Expert sessions over lunch on Monday and Tuesday. For further information, please check our Industry Meet the Expert lunch sessions here.

Session Schedule

These sessions will not be available on-demand after they're aired live.

Monday

From 18:00 to 19:00 CET

CODE TITLE EXPERT ROOM
MTE-1 Allogeneic CAR T cells: Progress and challenges Reuben Benjamin, UK MTE 1
MTE-2 Current role of HSCT in Acute Promyelocytic Leukemia Pau Montesinos, SP MTE 2
MTE-3 Improving results of HSCT in adult ALL Josep M. Ribera, SP MTE 3
MTE-4 How to diagnose and manage TA-TMA in 2021 Vincent Ho, USA MTE 4
MTE-5 The role of allogeneic HSCT in CLL in 2021 Peter Dreger, DE MTE 5

 

Tuesday

From 17:30 to 18:30 CET

CODE TITLE EXPERT ROOM
MTE-6 How to modulate the microbiome in HSCT Florent Malard, FR MTE 1
MTE-7  COVID-19 and other vaccines in HSCT recipients Simone Cesaro, IT MTE 2
MTE-8 What changes in conditioning regimens we should implement in 2021? Andrea Bacigalupo, IT MTE 3
MTE-9 Update on biomarkers for GVHD Kirk Schultz, CA MTE 4
MTE-10 Management of EBV-PTLD in 2021 Jan Styczynski, PL MTE 5

 

Wednesday

From 12:30 to 13:30 CET

CODE TITLE EXPERT ROOM
MTE-11 Post-transplantation cyclophosphamide as universal GVHD prophylaxis Ephraim Fuchs, USA MTE 1
MTE-12 Gene therapy for inborn errors ´come of age´ in 2021   Alain Fischer, FR MTE 2
MTE-13 How can we manage DLBCL relapse after CART therapy? Catherine Thieblemont, FR MTE 3
MTE-14 Managing thalassemia and other inherited disorders with HSCT Franco Locatelli, IT MTE 4
MTE-15 Allogeneic HSCT in multiple myeloma in the era of new drugs Sergio Giralt, USA MTE 5

 

Quality Management Meet the Expert

These sessions are free of charge and take place on the Tuesday of the meeting from 08:00 - 09:00 CET. Pre-registration is required via the general registration form.

CODE TOPIC EXPERT ROOM
QM MTE-1 Risk & Change Management Olga López Villar, SP
Dieter Klarmann, DE
MTE 1
QM MTE-2 Audits & Document Development and Control Julie Dolva, NO
Renza Monteleone, IT
MTE 2
QM MTE-3 Adverse events & CAPA Anne Emmett, UK MTE 3
QM MTE-4 Maintaining the QM program and QM plan Phuong Huynh, BE
Nick van Sinderen, NL
MTE 4
QM MTE-5 Outcome analysis and benchmarking & Validation and verification Mara Magri, IT
Kim Orchard, UK
MTE 5
QM MTE-6 Personnel, Training and Competency Sarah Holtby, UK MTE 6